Neurobiology of Aging
Volume 28, Issue 3 , Pages 327-335 , March 2007

Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease

  • Aneta Grudzien

      Affiliations

    • Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Feinberg School of Medicine, 320 East Superior Street, Searle 11-453, Chicago, IL 60611, USA
  • ,
  • Pamela Shaw

      Affiliations

    • Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Feinberg School of Medicine, 320 East Superior Street, Searle 11-453, Chicago, IL 60611, USA
  • ,
  • Sandra Weintraub

      Affiliations

    • Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Feinberg School of Medicine, 320 East Superior Street, Searle 11-453, Chicago, IL 60611, USA
  • ,
  • Eileen Bigio

      Affiliations

    • Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Feinberg School of Medicine, 320 East Superior Street, Searle 11-453, Chicago, IL 60611, USA
  • ,
  • Deborah C. Mash

      Affiliations

    • Department of Neurology, University of Miami School of Medicine, 1501 N.W. 9th Ave., Miami, FL 33136, USA
  • ,
  • M. Marsel Mesulam

      Affiliations

    • Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Feinberg School of Medicine, 320 East Superior Street, Searle 11-453, Chicago, IL 60611, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 312 908 9339; fax: +1 312 908 8789.

Received 15 July 2005 ,Revised 22 December 2005 ,Accepted 4 February 2006.

References 

  1. Benton AL, Hamsher KdS. Multilingual Aphasia Examination. Iowa City: University of Iowa; 1989;
  2. Benton AL. Revised visual retention test. New York: Psychological Corporation; 1974;
  3. Bondareff W, Mountjoy CQ, Rossor RM, Iversen LL, Reynolds GP, Hauser DL. Neuronal degeneration in the locus ceruleus and cortical correlates of Alzheimer's disease. Alzheimer Dis Assoc Discord. 1987;1(4):256–262
  4. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP. Age and histopathologic heterogeneity in Alzheimer's disease: evidence for subtypes. Arch Gen Psychiat. 1987;44(5):412–417
  5. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 1994;87:554–567
  6. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand. 1996;165(Suppl.):3–12
  7. Chan-Palay V, Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol. 1989;287(3):373–392
  8. Clayton EC, Rajkowski J, Cohen JD, Aston-Jones G . Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task. J Neurosci. 2004;24(44):9914–9920
  9. Craik FIM, Salthouse T. The handbook of cognitive aging. Mahwah, NJ: Lawrence Erlbaum; 2000;
  10. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–2391
  11. Devilbiss DM, Waterhouse BD. The effects of tonic locus ceruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat. J Neurosci. 2004;24(48):10773–10785
  12. Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiat. 1997;154:25–30
  13. Folstein M, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189–198
  14. Gatter KC, Powell TPS. The projection of the locus coeruleus upon the neocortex in the macaque monkey. Neuroscience. 1977;2:441–445
  15. Geula C, Mesulam MM. Cholinergic systems in Alzheimer's disease. In:  Terry RD,  Katzman R,  Bick KL,  Sisodia SS editor. Alzheimer Disease. 2nd ed.. Philadelphia: Lippincott Williams &Wilkins; 1999;p. 269–292
  16. Guillozet AL, Smiley JF, Mash DC, Mesulam MM. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol. 1997;42:909–918
  17. Hatanpää K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1996;40:411–420
  18. Ishii T. Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol. 1966;6:181–187
  19. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests’ norms above age 55: COWAT, BNT, MAE Token, WRAT-R Reading, AMNART, Stroop, TMT, and JLO. Clin Neuropsychol. 1996;10:262–278
  20. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Peterson RC, Kokmen E, et al. Mayo's older Americans normative studies: WMS-R norms for ages 56 through 94. Clin Neuropsychol. 1992;6(Suppl.):49–82
  21. Knight DP. Histochemical demonstration of the catecholamines and acetylcholine esterase in the same cell bodies in the locus ceruleus (rat hind brain). Proc R Microsc Soc. 1970;6:26
  22. Mann DMA, Yates PO, Hawkes J. The pathology of the human locus coeruleus. Clin Neuropathol. 1983;2:1–7
  23. Mann DMA, Yates PO, Marcyniuk B. Changes in Alzheimer's disease in the magnocellular neurons of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit. Clin Neuropathol. 1985;4(3):127–134
  24. Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase choline acetyltransferase. J Comp Neurol. 1988;275:216–240
  25. Mesulam MM. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 1999;24(3):521–529
  26. Mesulam MM, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol. 2004;55:815–828
  27. Mesulam MM, Van Hoesen W, Pandya DN, Geschwind N. Limbic and sensory connections of the inferior parietal lobule (area PG) in the rhesus monkey: a study with a new method for horseradish peroxidase histochemistry. Brain Res. 1977;136:393–414
  28. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–486
  29. Monteiro IM, Boksay I, Auer SR, Torossian C, Sinaiko E, Reisberg B. Reliability of routine clinical instruments for the assessment of Alzheimer's disease administered by telephone. J Geriatr Psychiat Neurol. 1998;11(1):18–24
  30. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39(9):1159–1165
  31. Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer's disease. Nat Med. 2004;10(Suppl. 5):S34–S41
  32. Ohm TG, Busch C, Bohl J. Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging. 1997;18(4):393–399
  33. Oishi M, Mochizuki Y, Yushihashi H, Takasu T, Nakano E. Laboratory examinations correlated with severity of dementia. Ann Clin Lab Sci. 1996;26:340–345
  34. Olszewski J, Baxter D. Cytoarchitecture of the human brain stem. 2nd ed.. Basel: Karger; 1982;
  35. Pearson J, Goldstein M, Brandeis L. Tyrosine hydroxylase immunohistochemistry in human brain. Brain Res. 1979;165:333–337
  36. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194
  37. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308
  38. Raskind MA, Peskind ER, Holmes C, Goldstein DS. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiat. 1999;46(6):756–765
  39. Robbins TW, Everitt BJ. Central norepinephrine neurons and behavior. In:  Bloom FE,  Kupfer DJ editor. Neuropsychopharmacology: the fourth generation of progress. New York: Raven Press; 1995;
  40. Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press; 1998;
  41. Tohgi H, Ueno T, Takahashi S, Nozaki Y. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer's type and vascular dementia of the Binswanger's type. J Neural Transm Park Dis Dement Sect. 1992;4:69–77
  42. Valentino RJ, Aston-Jones GS. Physiological and anatomical determinants of locus coeruleus discharge: behavioral and clinical implications. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995;
  43. Wechsler D. WAIS-R manual. New York: Psychological Corporation; 1981;
  44. Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol. 2003;60(3):337–341
  45. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 1990;47(20):209–214
  46. Zwieg RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 1988;24:233–242

PII: S0197-4580(06)00045-5

doi: 10.1016/j.neurobiolaging.2006.02.007

Neurobiology of Aging
Volume 28, Issue 3 , Pages 327-335 , March 2007